Pat-INFORMED
The Patent Information Initiative for Medicines (Pat-INFORMED) is a unique partnership between the World Intellectual Property Organization (WIPO) and IFPMA, where patent holders provide information about patents covering approved medicines through a free, open access database.
Overview
Pat-INFORMED features patent information for small molecule drugs for oncology, hepatitis C, cardiovascular, HIV, diabetes, and respiratory therapy areas, as well as any products on the WHO Essential Medicines List (EML) that are not within these therapy areas.
In a second phase, the initiative will extend to all therapeutic areas and explore the inclusion of complex therapeutics.
individual patents information are housed by Pat-INFORMED, for 600 patent families
INNs have information housed by Pat-INFORMED to date
the amount Pat-INFORMED has the potential to reduce medicine procurement timelines for low- and middle-income countries
A private-public partnership between WIPO and the innovative pharmaceutical industry, Pat-INFORMED is a practical step in helping to reduce the complexity surrounding patent information and make it easier for procurement experts to search the patent status of medicines.
Pat-INFORMED also provides a facility for procurement agencies to make follow-up inquiries directly with participating companies.
So far, Pat-INFORMED houses information on over 14,000 individual patents for 600 patent families and 169 International Non-proprietary Names (INNs) that are globally recognized and used to identify pharmaceutical substances or active pharmaceutical ingredients within medicines that cover a wide range of conditions.
Search the Pat-INFORMED database
Discover how to access relevant information about a medicine’s patent status and open the gateway to medicine patent information.
Other partnerships and alliances
See all
The International Council for Harmonisation (ICH)
As a Standing Observer of ICH, IFPMA along with other ICH Members and Observers, has an important role in promoting global convergence toward ICH regulatory standards and their harmonized interpretation.
INTREPID Alliance
INTREPID Alliance exists to accelerate the development of new treatments for emerging viral pandemic agents through coordinated early science and R&D, policy and advocacy and stakeholder engagement. INTREPID Alliance members collectively bring expertise in drug discovery, antiviral R&D and medicine manufacturing.
Navigating Innovation & Research Opportunities (NIRO)
Helping actors in research and innovation identify opportunities within and beyond the European Union